Cancer Commons

Partnerships:cancer commons collaborates with organizations that share its patient-focused approach to cancer care. Through a partnership with xcures, cancer commons patients are invited to enroll in xcelsior, a platform trial that integrates precision oncology insights with cuttingedge technology to offer innovative treatment opportunities.cancer commons also maintains partnerships with institutions and organizations supporting patients with complex cancer cases. These entities either refer patients needing expert guidance or provide specialized services directly. Key partnerships in fy2024 included the musella foundation for brain tumor research & information and head for the cure.

Learning health system development:cancer commons developed a prototype learning health system (lhs) software aimed at advancing treatment recommendations through technology. The system is designed to combine real-world patient data and ai analysis to help refine decision-making and assist oncologists in identifying optimal treatment options for patients with advanced cancers.this demo version of the lhs was designed to process and analyze patient cases, assessing its potential to speed up decision-making and provide oncologists with useful, data-driven insights. These efforts lay the foundation for a more efficient case review process with the goal of expanding cancer commons' ability to support more patients and contribute valuable insights to cancer research and care.